Bottom line
What is LLMRX's expense ratio?
LLMRX's expense ratio is 1.39%, or about $139 a year on every $10,000 invested. That is more expensive than 81% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated May 26, 2026
LLMRX fee table
| Net expense ratio | 1.39% |
|---|---|
| Gross expense ratio | 2.14% |
| Management fee | 0% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 1.05% |
| Acquired fund fees | 0.59% |
| Fee waiver / reimbursement | -0.75% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed May 26, 2026
What LLMRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| LLMRX | $142 | $598 | $1,081 | $2,414 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.39% expense ratio costs roughly $74,400 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).